No Data
Yingqu Technology: 2024 Annual Results Forecast
Xiamen Intretech Inc. (002925.SZ): The net income is expected to decrease by 40%-50% for the year 2024.
On January 17, Gelonghui announced that Xiamen Intretech Inc. (002925.SZ) released its annual performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be between 0.225 billion yuan and 0.27 billion yuan, a decrease of 40% to 50% compared to the same period last year; the net income after deducting non-recurring gains and losses is expected to be between 0.193 billion yuan and 0.232 billion yuan, a decrease of 40% to 50% compared to the same period last year; the basic EPS is expected to be between 0.30 yuan/share and 0.36 yuan/share. The revenue for 2024 is expected to be between 3.475 billion yuan and 3.667 billion yuan, a year-on-year decrease of approximately 5% to 10%, and the gross margin is expected.
Xiamen Intretech (SZSE:002925) Sheds CN¥1.3b, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Xiamen Intretech Inc. (002925.SZ): has repurchased a total of 0.1841% of its shares.
On January 2, Galunhui reported that Xiamen Intretech Inc. (002925.SZ) announced that as of December 31, 2024, the company had repurchased 1,431,400 shares through a dedicated stock buyback account via centralized bidding, accounting for 0.1841% of the company's current total share capital, with the highest Fill Price of 14.18 yuan/share, the lowest Fill Price of 13.62 yuan/share, and a total amount of 19,998,154.50 yuan (excluding transaction fees).
Investors Appear Satisfied With Xiamen Intretech Inc.'s (SZSE:002925) Prospects
Xiamen Intretech Inc. (002925.SZ): In the area of Brain-computer Interface, the company has developed a headset EEG monitoring product in collaboration with the customer InteraXon, which has already been launched and sold in North America.
On December 17, Gelonghui reported that Xiamen Intretech Inc. (002925.SZ) stated on the investor interaction platform that in the area of Brain-computer Interface, the company has already developed a headset EEG monitoring product in cooperation with the client InteraXon, and it has been launched and sold in North America. Currently, the company is collaborating with Xiamen Beiyang Ruiheng Smart Health Co., Ltd. to launch research, medical, education, and focus versions of Brain-computer Interface products; Tianjin University has adopted the EEG products produced by the company as part of a Brain-computer Interface training course, making it the first training course for graduate students in this field in China. The company is currently working with multiple parties to carry out brain...
Xiamen Intretech (SZSE:002925) May Have Issues Allocating Its Capital
